ClinicalTrials.gg
Not yet recruitingNCT07542821MHPIIUpdated Apr 21, 2026

Cancer Survivors' Fear of Cancer Recurrence

An interventional study of psycological cognitive training and Healthy lifestyle in Fear of Cacer Recurrence in Cancer Survivorws, sponsored by National Taipei University of Nursing and Health Sciences. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by National Taipei University of Nursing and Health Sciences · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop and evaluate the tailored support for the fear of cancer recurrence in breast, head and neck, colon-rectal or prostate cancer survivors. Based on screening for fear of cancer recurrence, different levels of supportive care will be provided, starting with the oncology nurses' health education and information for those having a lower level of concern. Those who have medium or higher levels of concerns will be randomized to receive "stepping up" either a "ConquerFear psychological cognitive training" or a "healthy lifestyle - individualized exercise and nutrition guidance".

02

Conditions studied

  • Fear of Cacer Recurrence in Cancer Survivorws

Keywords

  • Fear of cancer recurrence
  • cancer survivor
  • psychosoical support
  • ConquerFear
  • Healthy life style
03

In context

Lead sponsor

National Taipei University of Nursing and Health Sciences is the lead sponsor of 124 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • stage I, II, III breast, head and neck, colo-rectal, proste cancer and completion of primary cancer treatment
  • report of fear of cancer recurrence
  • able to read and listen in Manderin and without a cognitive defect

Exclusion criteria

Exclusion Criteria:

  • diagnosed with severe mental illness
  • difficult to communicate in Manderin
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Active comparator
    education group

    one session of nurses' education and information

    Behavioral: education

  • Experimental
    ConquerFear group

    a 6-session add-on psychological cognitive training performed by a trained psychologist

    Behavioral: psycological cognitive training · Behavioral: education

  • Experimental
    Healthy lifestyle group

    a 6-session add-on individualized nutrition and exercise guidance performed by a trained nutritionist and an exercise expert.

    Behavioral: Healthy lifestyle · Behavioral: education

Interventions

  • Behavioralpsycological cognitive training

    Metacognition

    Also known as: ConquerFear

  • BehavioralHealthy lifestyle

    individualized nutrition and exercise guidance

    Also known as: nutrition counseling, excercise training

  • Behavioraleducation

    FCR education

06

What researchers measure

Primary outcomes

  1. Fear of Cance Recurrence

    the change of FCR (Fear of Cancer Recurrence) score as measured by FCRI

    Time frame: From the baseline to the 3 months after intervention at 5 months

Secondary outcomes

  1. Psychological distress

    the change of the anxiety and depression as measured by HADS

    Time frame: From the baseline to the 3 months after intervention at 5 months

  2. QOL

    The change of the quality of life score as measured by VR-12

    Time frame: From the baseline to the 3 months after intervention at 5 months

Other outcomes

  1. Metacognition

    the change of metacognition as measured by MCQ-30

    Time frame: From the baseline to the 3 month after intervention at 5 months

  2. Intervention Satisfaction

    the score of self-designed satisfaction score with the intervention

    Time frame: at the end of intervention at 2 month

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Park SY, Lim JW. Cognitive behavioral therapy for reducing fear of cancer recurrence (FCR) among breast cancer survivors: a systematic review of the literature. BMC Cancer. 2022 Feb 28;22(1):217. doi: 10.1186/s12885-021-08909-y. PubMed 35227244 ↗
  • Ng DWL, Ng R, Guo C, Chan J, Fielding R, Tang JWC, Li WWY, Foo CC, Kwong A, Ng SS, Suen D, Fung S, Chun OK, Chan KKL, Chang ATY, Butow P, Lam WWT. ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors. Psychother Psychosom. 2026;95(2):117-133. doi: 10.1159/000547888. Epub 2025 Aug 8. PubMed 40784346 ↗

Individual participant data

Plan to share: No — It is restricted by the sponsors.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07542821
Collaborators
Ministry of Health and Welfare, Taiwan, Koo Foundation Sun Yat-Sen Cancer Center
Responsible party
Shiuyu Katie Lee,RN MSN PhD (Associate Professor, National Taipei University of Nursing and Health Sciences) — Principal investigator
First posted
Apr 21, 2026
Start date
Apr 15, 2026 (estimated)
Primary completion
May 31, 2028 (estimated)
Completion
Nov 30, 2028 (estimated)
Last update
Apr 21, 2026

Study contacts

Shiuyu C. Katie Lee
Contact
shiuyu@ntunhs.edu.tw
886961395150
Shiao-Wei Cheng
Contact
study1042@ntunhs.edu.tw
886919885149
Shiuyu C. Katie Lee, PhD
principal investigator · National Taipei University of Nursing and Health Science

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion